InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.30
(
-0.55%
)
Bitcoin
56,636.19
(
-2.86%
)
Post# of 252504
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119984
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Bickema post# 193986

Friday, 07/31/2015 2:25:53 PM

Friday, July 31, 2015 2:25:53 PM

Post# of 252504
OCRX—The loan is at least as palatable as the $25M underwritten equity offering I was expecting (assuming that the interest rate is commensurate with the other terms of the deal).

OCRX still needs a partner in order to develop both the IV and oral formulations of OCR-002, but the new loan gives OCRX a little more flexibility in crafting a deal.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up